Peptide therapeutics operate through a variety of mechanisms depending on their structure and target. Many peptides act as receptor agonists, binding to specific receptors on the cell surface to activate signaling pathways that promote beneficial physiological effects. Others serve as antagonists, blocking pathological signaling or inhibiting enzymes involved in disease processes.

For example, peptide hormones such as insulin analogs bind to insulin receptors to regulate glucose metabolism. Antimicrobial peptides disrupt bacterial membranes, providing a rapid and targeted approach to infectious diseases. Some peptides can penetrate cells to modulate intracellular pathways or gene expression, offering potential in cancer therapy and rare genetic disorders.

Advances in molecular modeling and peptide engineering allow for the optimization of binding affinity, stability, and specificity. Modifications such as cyclization, incorporation of non-natural amino acids, or conjugation to carriers can enhance the pharmacokinetic profile and therapeutic efficacy.

The precision and versatility of peptide mechanisms make them particularly attractive for conditions where conventional therapies are limited or carry high toxicity. By leveraging natural biological processes, peptide therapeutics offer targeted intervention with minimized systemic effects.